As we look back on the past year, we are proud of the progress and impact reflected in these highlights. None of this would have been possible without the close collaboration, trust, and pioneering spirit of the researchers at Utrecht University and UMC Utrecht. We would like to extend our...

Utrecht Holdings is proud to offer a patent-pending CAR-T cell therapy platform developed by researchers at UMC Utrecht.

As coordinator of the research project Neoliver, Bart Spee leads the international consortium of twelve research institutions and companies. Below is an article in Trouw about the development of the Neoliver.

Ready to turn your Science into Impact? Together with the Faculty of Impact, we have organized an information session at our office. Do you have any questions or are you interested? Come by to our office (Bestuursgebouw 0.43) and Sandy Kalisingh and Leon Gielgens from NWO will be present to...

We can look back on another great, innovative year. We thank all researchers from the UU and the UMCU.